With over 7 years of experience in the Pharma/FMCG/Medtech industry, my career is characterized by corporate development expertise. I've adeptly managed deal appraisal, conducting thorough evaluations of buy-side opportunities across prescription drugs, medical devices, supplements, and cosmetics, spanning Europe, the US, and APAC.Guiding cross-functional teams through end-to-end projects, I've effectively facilitated due diligence and presented comprehensive insights to C-level decision-makers. My negotiation proficiency is complemented by adept financial modeling, encompassing due diligence, business case development, and valuation.I excel in drafting agreements, collaborating with legal and functional experts to structure intricate deals. With a well-established network covering M&A brokers and industry peers within the healthcare sector, I remain committed to driving strategic projects for ventures in the Pharma/FMCG/Medtech world and adjacent sectors.My accomplishments include contributing to the successful closure of significant acquisitions:• $80M in Rx/Consumer Health, APAC, 2018• $110M in Consumer Health, US, 2020• $19M in Consumer Health, US, 2022Please contact me for any business or job enquiries